Health Canada — Medical Devices · Canada · 2018-01-29 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Erroneous results may occur as a result of a software issue when specific conditions occur with the Phadia 250. The issue can occur with all versions of the Phadia Prime Software up to and including version 2.1.4. The issue will cause software to disregard default dilution factors for rejected samples, when using the "ok to all" function for retesting of samples if specific criteria are met.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.